Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.35% | 62.98 | 1.0% | $410.78m | |
| AMGN | Amgen, Inc. | 0.41% | 241.49 | 1.3% | $404.45m | |
| BIIB | Biogen, Inc. | -0.22% | 285.50 | 1.4% | $345.61m | |
| ILMN | Illumina, Inc. | -0.38% | 324.72 | 3.5% | $314.55m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.14% | 235.83 | 1.9% | $273.15m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.10% | 385.94 | 2.6% | $211.56m | |
| EXAS | EXACT Sciences Corp. | -1.92% | 88.06 | 24.0% | $200.81m | |
| ITCI | Intra-Cellular Therapies, Inc. | -1.43% | 26.25 | 9.0% | $186.59m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.68% | 113.27 | 2.0% | $174.71m | |
| INCY | Incyte Corp. | -0.15% | 80.50 | 2.5% | $140.53m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.84% | 127.90 | 14.6% | $135.49m | |
| A | Agilent Technologies, Inc. | 0.79% | 90.17 | 1.6% | $114.69m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.97% | 88.27 | 4.3% | $106.23m | |
| BLUE | bluebird bio, Inc. | 0.59% | 98.04 | 14.2% | $94.93m | |
| SGEN | Seattle Genetics, Inc. | 1.25% | 109.00 | 6.1% | $89.92m |
Company Profile
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.